These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30458933)

  • 61. Creating reliable pharmaceutical distribution networks and supply chains in African countries: Implications for access to medicines.
    Tetteh E
    Res Social Adm Pharm; 2009 Sep; 5(3):286-97. PubMed ID: 19733829
    [No Abstract]   [Full Text] [Related]  

  • 62. Should non-citizens have access to publicly funded health care?: a study of public attitudes and their affecting factors.
    Sun LY; Lee EW; Zahra A; Park JH
    Public Health; 2015 Sep; 129(9):1157-65. PubMed ID: 26298590
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A new approach to gathering pharmaceutical market data to support policy implementation and access to medicines: as demonstrated by malaria medicines in Zambia.
    Coghlan R; Stephens P; Mwale B; Siyanga M
    Malar J; 2018 Nov; 17(1):444. PubMed ID: 30497504
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [The judicialisation of health as a means ensuring access to medicines].
    Leitão LC; Simões MO; Simões AE; Alves BC; Barbosa IC; Pinto ME
    Rev Salud Publica (Bogota); 2014; 16(3):361-70. PubMed ID: 25521951
    [TBL] [Abstract][Full Text] [Related]  

  • 65. National Medicines Policy in retrospective: a review of (almost) 20 years of implementation.
    Vasconcelos DMM; Chaves GC; Azeredo TB; Silva RMD
    Cien Saude Colet; 2017 Aug; 22(8):2609-2614. PubMed ID: 28793076
    [TBL] [Abstract][Full Text] [Related]  

  • 66. How the Trans Pacific Partnership Agreement could undermine PHARMAC and threaten access to affordable medicines and health equity in New Zealand.
    Gleeson D; Lopert R; Reid P
    Health Policy; 2013 Oct; 112(3):227-33. PubMed ID: 23992756
    [TBL] [Abstract][Full Text] [Related]  

  • 67. New funding arrangements in the Italian National Health Service.
    Jommi C; Cantù E; Anessi-Pessina E
    Int J Health Plann Manage; 2001; 16(4):347-68. PubMed ID: 11771152
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [National pharmaceutical policy in Colombia and social security reform: access and rational use of medicines].
    Mejia Restrepo S; Velez Arango AL; Buritica Arboleda OC; Arango Mejia MC; Rio Gomez JA
    Cad Saude Publica; 2002; 18(4):1025-39. PubMed ID: 12118308
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Early access programs for medicines: comparative analysis among France, Italy, Spain, and UK and focus on the Italian case.
    Tarantola A; Otto MH; Armeni P; Costa F; Malandrini F; Jommi C
    J Pharm Policy Pract; 2023 May; 16(1):67. PubMed ID: 37198599
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [The heart of Italians. A population survey on the perception and evaluation of the National Health Service by citizens with heart disease and without heart disease (with special reference to cardiology)].
    Ottani F; La Vecchia L; Diamanti I; Pozzati A; Gardani L; Fresco C; Lettino M; Cuccia C
    G Ital Cardiol (Rome); 2015 May; 16(5):304-10. PubMed ID: 25994467
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Between the court and the clinic: lawsuits for medicines and the right to health in Brazil.
    Biehl J; Amon JJ; Socal MP; Petryna A
    Health Hum Rights; 2012 Jun; 14(1):E36-52. PubMed ID: 22773096
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Differences in the availability of new anti-cancer drugs for Italian patients treated in different regions. Results of analysis conducted by the Italian Society Of Medical Oncology (AIOM).
    Gori S; Di Maio M; Pinto C; Alabiso O; Baldini E; Beretta GD; Caffo O; Caroti C; Crinò L; De Laurentiis M; Dinota A; Di Vito F; Gebbia V; Giustini L; Graiff C; Guida M; Lelli G; Lombardo M; Muggiano A; Puglisi F; Romito S; Salvagno L; Tagliaferri P; Terzoli E; Venturini M;
    Tumori; 2010; 96(6):1010-5. PubMed ID: 21388067
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evaluation of the implementation outcomes of the Essential Medicines System in Anhui county-level public hospitals: a before-and-after study.
    Xu S; Bian C; Wang H; Li N; Wu J; Li P; Lu H
    BMC Health Serv Res; 2015 Sep; 15():403. PubMed ID: 26394615
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Medicines use in Italy. 2020 OsMed National Report.].
    Zito S; Fortinguerra F; Pierantozzi A; Ambrosino F; Traversa G; Trotta F; Da Cas R; Cangini A
    Recenti Prog Med; 2021 Oct; 112(10):659-667. PubMed ID: 34647536
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Addressing the impact of economic sanctions on Iranian drug shortages in the joint comprehensive plan of action: promoting access to medicines and health diplomacy.
    Setayesh S; Mackey TK
    Global Health; 2016 Jun; 12(1):31. PubMed ID: 27267898
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The morally uncomfortable global drug gap.
    Cohen-Kohler JC
    Clin Pharmacol Ther; 2007 Nov; 82(5):610-4. PubMed ID: 17898710
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Initiatives to promote access to medicines after publication of the Brazilian Policy on the Comprehensive Care of People with Rare Diseases.
    Cunico C; Vicente G; Leite SN
    Orphanet J Rare Dis; 2023 Aug; 18(1):259. PubMed ID: 37653461
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Portuguese Global Medicines Access Index 2021: An Indicator to Measure Access to Hospital Medicines.
    Oliveira-Martins S; Lopes MC; Cardoso Dos Santos A; Advinha AM
    Value Health Reg Issues; 2024 May; 41():80-85. PubMed ID: 38262256
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Disparity in the "time to patient access" to new anti-cancer drugs in Italian regions. Results of a survey conducted by the Italian Society of Medical Oncology (AIOM).
    Gori S; Di Maio M; Pinto C; Alabiso O; Baldini E; Barbato E; Beretta GD; Bravi S; Caffo O; Canobbio L; Carrozza F; Cinieri S; Cruciani G; Dinota A; Gebbia V; Giustini L; Graiff C; Molino A; Muggiano A; Pandoli G; Puglisi F; Tagliaferri P; Tomao S; Venturini M;
    Tumori; 2011; 97(4):442-8. PubMed ID: 21989431
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Horizon Scanning for pharmaceuticals and effective health care programming: 2 years' experience at the Italian Medicines Agency.
    Ivanovic J; Capone G; Raffaelli L; Pantò V; Marangi M
    Drug Discov Today; 2021 Feb; 26(2):569-576. PubMed ID: 33220432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.